THE recommendation to administer a first booster dose to the 12-17 year age bracket was already submitted to the Food and Drug Administration (FDA) according to a vaccine expert.
However, Dr. Nina Gloriani, chairperson of the vaccine expert panel, said the final decision and recommendation regarding this rests on the hands of the Health Technology Assessment Council (HTAC).
Gloriani said that the HTAC needed to study the situation if booster shots should be given to the 12-17 year-olds, which has a stronger immune system compared to adults and the elderly.
As for the 5-11 year-old kids, Gloriani said they still have no recommendation to give them booster doses.
Meanwhile, Gloriani said for the general public and healthier individuals, they are still studying whether to give the second booster dose.
In Gloriani’s assessment, this may take a while since they have to prioritize those in the A3 category or those with controlled comorbidities for their second booster dose.